{
    "id": "56698310",
    "text": "Mirikizumab (INN; development code LY3074828) is a human monoclonal antibody designed for the treatment of psoriasis. This drug was developed by Eli Lilly and Co.Statement On A Nonproprietary Name Adopted By The USAN Council - Mirikizumab, American Medical Association. , mirikizumab is undergoing Phase III trials. == References == Category:Monoclonal antibodies ",
    "title": "Mirikizumab"
}